IP Library Granted Patent US 11,111,434
Granted Patent B2
US 11,111,434 · App. 16/007,118 · Granted Sep 7, 2021

Light emitter, method for producing light emitter, and biological substance labeling agent

Inventors: Takahito Nagano (Nagaokakyo, JP); Norikazu Fujihira (Nagaokakyo, JP)
Assignee: MURATA MANUFACTURING CO., LTD.
C09K11/88A61K49/0019A61K49/0065B82Y40/00B82Y5/00B82Y15/00B82Y20/00B82Y30/00Y10S977/773Y10S977/896Y10S977/927
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,111,434
App. No.
16/007,118
Granted
Sep 7, 2021
Kind
B2
Abstract

A light emitter is formed from nanoparticles including a compound semiconductor containing an Ag component, In component, and Se component. The peak wavelength of the emission intensity falls within the range of 700 to 1400 nm, and the half-value width ΔH for the peak wavelength is 100 nm or less. The light emitted is configured to emit strong light in the near-infrared region, and which is capable of detecting biological information, and is preferred for bioimaging.

Claims (9)

1. A light emitter for labeling a biological substance, the light emitter comprising:

nanoparticles composed of a compound semiconductor that contains an Ag compound, an In component, and a Se component,

wherein the compound semiconductor is a light-emitting material that emits light at an emission intensity having a peak wavelength within a range between 700 nm and 1400 nm, and

wherein a mixing ratio of the In component to the Ag component is between 2 and 3 in terms of molar ratio, such that the light-emitting material is constructed to emit light at the emission intensity having the peak wavelength that is 85 nm or less in half-value width.

2. The light emitter according to claim 1 , wherein the peak wavelength is between 700 nm and 1000 nm.

3. The light emitter according to claim 1 , wherein the compound semiconductor contains the In component in excess with respect to the stoichiometric composition of the compound semiconductor.

4. The light emitter according to claim 1 , wherein the emitted light comprises an absorption wavelength with at least a portion between 700 nm and 1000 nm.

5. The light emitter according to claim 1 , wherein the compound semiconductor has an average particle size between 0.1 nm and 20 nm.

6. A biological substance labeling agent comprising the light emitter according to claim 1 .

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND INVENTORS LAST NAME PREVIOUSLY RECORDED ON REEL 046071 FRAME 0479. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Oct 26, 2018
From: NAGANO, TAKAHITO; FUJIHIRA, NORIKAZU
To: MURATA MANUFACTURING CO., LTD.
Reel/Frame 048538/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2018
From: NAGANO, TAKAHITO; FUJIHARA, NORIKAZU
To: MURATA MANUFACTURING CO., LTD.
Reel/Frame 046071/0479 →
Priority Claims (1)
JP JP2016-007856 · Jan 19, 2016 · national
Continuity (2)
Continuation PCTJP2016078513 · Sep 27, 2016
Related Publication 20180291267A1 · Oct 11, 2018